MedPath

Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)

Completed
Conditions
Patient-reported Outcomes
Registration Number
NCT03341377
Lead Sponsor
Xiaojun Yang
Brief Summary

Investigators propose a multicenter prospective observational cohort study to develop and validate essential technical parameters for establishing the patient-reported outcome-based perioperative symptom management cohort in patients with lung cancer. With at least 300 patients with initial diagnosis of lung cancer and scheduled for surgery, this study will administer symptom assessments (MDASI-LC) and quality of life assessments (SIQOL) before surgery (typically within 3 days before surgery), daily after surgery (in hospital ≤ 14 days), and weekly after discharge, up to 4 weeks (±3 days) or the start day of postoperative oncologic treatment. In the upgraded research protocol, symptom and quality of life assessments (every 3 month for 1 year, every 6 month for 2-3 year, every 12 month for 4-5 year), as well as the follow-up of clinical outcomes will continue until 5 years after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
512
Inclusion Criteria
  1. Be pathologically or clinically diagnosed as primary lung cancer before surgery;
  2. Plan to undergo a surgical procedure.
Exclusion Criteria
  1. Aged younger than 18;
  2. Diagnosis of cognitive impairment or unable to understand the study requirements.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Perioperative symptom burden (severity, freqency and impact on daily functioning) measured by MDASI-LCless than 6 weeks

We will use MD Anderson Symptom Inventory lung cancer module (MDASI-LC) to longitudinally assess the perioperative symptom burden for lung cancer patients. The symptom burden will be profiled as symptom severity, frequency of moderate to severe symptom and its interference with daily functioning.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Jiangyou People's Hospital

🇨🇳

Jiangyou, Sichuan, China

Zigong First People's Hospital

🇨🇳

Zigong, Sichuan, China

Sichuan Cancer Hospital and Research Institute

🇨🇳

Chengdu, Sichuan, China

Chengdu Seventh People's Hospital

🇨🇳

Chengdu, Sichuan, China

Chengdu Third People's Hospital

🇨🇳

Chengdu, Sichuan, China

Dazhu County People's Hospital

🇨🇳

Dazhou, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath